Companies: 10,795·Total market cap: $144.5T
Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATBPFOTCHealthcare
$0.22
$-0.00(-0.19%)
Market Cap$11428827
P/E Ratio—
52W High$0.216
52W Low$0.1889
Overview

Antibe Therapeutics Inc. (ATBPF) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

ATBPF · shares outstanding · updated Jun 10, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
52.3M▲ +2.98% YoY Change
FY · as of Mar 31, 2023 · Reported in CAD
vs 50.8M in FY 2022
Diluted Shares Outstanding
52.3M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+2.98%
year-over-year
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-10

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+24.2%
2020 → 2023
5-Year CAGRincreasing
+28.1%
2018 → 2023
10-Year CAGRincreasing
+35.0%
2013 → 2023
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2023Latest
Diluted Shares: 52.3M
52.3M
+2.98%
FY 2022
Diluted Shares: 50.8M
50.8M
+36.30%
FY 2021
Diluted Shares: 37.3M
37.3M
+36.62%
FY 2020
Diluted Shares: 27.3M
27.3M
+26.90%
FY 2019
Diluted Shares: 21.5M
21.5M
+41.72%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs ATBPF
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+>999%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+>999%
#7
Antibe Therapeutics Inc.ATBPF
Antibe Therapeutics Inc.YOU
52.3M—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Antibe Therapeutics Inc. (ATBPF) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of March 31, 2023, Antibe Therapeutics Inc. reports 52.3M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Antibe Therapeutics Inc.'s basic shares outstanding (52.3M) represents currently issued shares. Diluted shares outstanding (52.3M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

Antibe Therapeutics Inc.'s float is — (— of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · CAD

About shares outstanding & methodology

Antibe Therapeutics Inc. (ATBPF) shares outstanding history from 2012 to 2023. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Antibe Therapeutics Inc. shares outstanding for the fiscal year ending March 31, 2023 were 52.3M, a 2.98% increase year-over-year. Antibe Therapeutics Inc. FY 2023 shares outstanding were 52.3M, a +2.98% increase from FY 2022.

Antibe Therapeutics Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +35.0% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

ATBPF shares outstanding · 4 questions

As of March 31, 2023, Antibe Therapeutics Inc. (ATBPF) has approximately 52.3M basic shares outstanding and 52.3M diluted shares outstanding. This represents a +2.98% year-over-year increase from FY 2022 (50.8M). The increase may reflect equity compensation issuances or secondary offerings.

ATBPF shares outstandinghow many shares does ATBPF haveATBPF basic shares 2023ATBPF diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Antibe Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-10